About Kanvas Biosciences
Kanvas Biosciences is a company based in Ithaca (United States) founded in 2021 by Iwijn De Vlaminck and Matthew P Cheng. Kanvas Biosciences has raised $24.28 million across 3 funding rounds from investors including Germin8, DCVC and Lion Capital. Kanvas Biosciences offers products and services including Spatial Mapping Platform and Live Biotherapeutics Pipeline. Kanvas Biosciences operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others.
- Headquarter Ithaca, United States
- Founders Iwijn De Vlaminck, Matthew P Cheng
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$24.28 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Germin8
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kanvas Biosciences
Kanvas Biosciences offers a comprehensive portfolio of products and services, including Spatial Mapping Platform and Live Biotherapeutics Pipeline.
Platform for mapping host-microbiome interactions in drug discovery.
Pipeline for microbiome-modulating treatments in health and disease.
People of Kanvas Biosciences
Unlock access to complete
Funding Insights of Kanvas Biosciences
Kanvas Biosciences has successfully raised a total of $24.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kanvas Biosciences
Kanvas Biosciences has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Germin8, DCVC and Lion Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Private equity firm focused on consumer brands
|
Locked | Locked | Locked | |
|
Investments are focused on innovations in women's health.
|
Locked | Locked | Locked |
Investor details for Kanvas Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kanvas Biosciences
Investment portfolio details for Kanvas Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kanvas Biosciences
Detailed financials for Kanvas Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kanvas Biosciences Comparisons
Peer comparison for Kanvas Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kanvas Biosciences
Kanvas Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Novel dermatologic therapies are developed for skin conditions.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
Detailed competitors of Kanvas Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kanvas Biosciences
Complete news archive for Kanvas Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanvas Biosciences
Kanvas Biosciences was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Kanvas Biosciences is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Kanvas Biosciences is a funded company, having raised a total of $24.28M across 3 funding rounds to date.
Kanvas Biosciences was founded in 2021 in Ithaca, United States, as a provider in the biotechnology sector. Solutions focused on imaging for microbial research and infectious diseases are developed and offered. Operations center on advancing tools for scientific applications in these areas. The company is co-founded by Iwijn De Vlaminck and Matthew P Cheng, with activities based in the United States.
Kanvas Biosciences's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Kanvas Biosciences offers Spatial Mapping Platform and Live Biotherapeutics Pipeline.
Kanvas Biosciences has 9 investors. Key investors include Germin8, DCVC, Lion Capital, FemHealth Ventures, and Ki Tua Fund.